Cancer screening, overdiagnosis, and regulatory capture

JAMA Internal Medicine

Volumn 177, Issue 7, 2017, Pages 915-916

  Welch, H Gilbert ^a  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER SCREENING; DECISION MAKING; ECHOGRAPHY; EDITORIAL; HORMONAL THERAPY; HUMAN; MEDICAL CARE; PHYSICAL EXAMINATION; POSITIVE FEEDBACK; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH MESSAGE; THYROID CANCER; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; X-RAY COMPUTED TOMOGRAPHY; ADVISORY COMMITTEE; ASYMPTOMATIC DISEASE; EARLY CANCER DIAGNOSIS; ECONOMICS; HEALTH SERVICE; HISTORY; INCIDENCE; MORTALITY; PREVENTION AND CONTROL; PREVENTIVE HEALTH SERVICE; PROCEDURES; RISK ASSESSMENT; STANDARDS; STATISTICS AND NUMERICAL DATA; THYROID TUMOR; TRENDS; UNITED STATES;

ADVISORY COMMITTEES; ASYMPTOMATIC DISEASES; EARLY DETECTION OF CANCER; HISTORY, 20TH CENTURY; HUMANS; INCIDENCE; MEDICAL OVERUSE; MORTALITY; PREVENTIVE HEALTH SERVICES; RISK ASSESSMENT; THYROID NEOPLASMS; UNITED STATES;

EID: 85024477461     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2017.1198     Document Type: Editorial

References (19)

1. US Preventive Services Task Force. Screening for thyroid cancer [published May 9, 2017]. JAMA. doi:10.1001/jama.2017.4011
2. Cole WH, Slaughter DP, Rossiter LJ. Potential dangers of nontoxic nodular goiter. JAMA. 1945;127 (14):883-888. doi:10.1001/jama.1945.02860140001001
3. Hinton JW, Lord JW. Is surgery indicated in all cases of nodular goiter, toxic and nontoxic? JAMA. 1945;129(9):605-606. doi:10.1001/jama.1945.02860430021006
4. Vanderlaan WP. The occurrence of carcinoma of the thyroid gland in autopsy material. N Engl J Med. 1947;237(7):221-222.
5. Harach HR, Franssila KO,Wasenius VM. Occult papillary carcinoma of the thyroid: a "normal" finding in Finland. Cancer. 1985;56(3):531-538.
6. Welch HG. Should I Be Tested for Cancer? Oakland, CA: University of California Press; 2006:79-82.
7. SEER∗Stat Database. Incidence-1973-2013. https://seer.cancer.gov/data/seerstat/nov2015/. Accessed April 7, 2017.
8. SEER∗Stat Database. Mortality-1969-2013. https://seer.cancer.gov/data/citation.html. Accessed April 7, 2017.
9. Davies L, OuelletteM, Hunter M,Welch HG. The increasing incidence of small thyroid cancers. Laryngoscope. 2010;120(12):2446-2451.
10. Light of Life Foundation. Confidence Kills. http://lightoflifefoundation.org/advocacy/campaigns/confidence-kills/. Accessed April 20, 2017.
11. Light of Life Foundation. Sponsors and partners. http://lightoflifefoundation.org/about-us/sponsors-and-partners/. Accessed April 20, 2017.
12. Ahn HS, Kim HJ,Welch HG. Korea's thyroid-cancer "epidemic". N Engl J Med. 2014;371 (19):1765-1767.
13. Welch HG, Schwartz LM,Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA. 2000;283(22):2975-2978.
14. Raffle AE, Gray JAM. Screening: Evidence and Practice. Oxford: Oxford University Press; 2007.
15. Koreakoreakorea. Thyroid cancer. http://www.koreakoreakorea.com/package/thyroid-cancer/. Accessed April 5, 2017.
16. Allen M. HHS Nominee TomPrice targeted panel that urged fewer cancer screenings. https://www.propublica.org/article/hhs-nominee-tom-price-targeted-panel-that-urged-fewer-cancer-screenings. Accessed April 5, 2017.
17. Ault A. GOP begins new scrutiny of US Preventive Services Task Force. http://www.medscape.com/viewarticle/872599. Accessed April 5, 2017.
18. 114th Congress (2015-2016). H.R.1151-USPSTF Transparency and Accountability Act of 2015. https://www.congress.gov/bill/114th-congress/house-bill/1151?q=. Accessed April 5, 2017.
19. Wikipedia. Regulatory capture. https://en.wikipedia.org/wiki/Regulatory-capture. Accessed April 5, 2017.